Your Era GLP-1 Reviews: Is YourEra Legit, and What Does $79 Really Buy?

Affiliate disclosure: Provider links on The RX Index may be affiliate links. If a link on this page routes you through an affiliate partner and you start a program, The RX Index may earn a commission at no extra cost to you. Source, regulator, and policy links are not paid placements. It does not change what we found, what we scored, or what we recommend. We tell you when we think you should pick someone else.

You found YourEra while reading Your Era GLP-1 reviews. The price says $79 a month. Your gut says that's either the best deal in weight loss right now — or a trap.

Here's the short version.

YourEra appears to be a real operating telehealth business. It advertises compounded semaglutide from $79 a month and compounded tirzepatide from $159 a month. YourEra says licensed clinicians review prescriptions and state-licensed U.S. pharmacies ship the medication. Its Terms use the name YourEra, Inc.; its Privacy Policy names Your Era Management, LLC at a Covington, Louisiana address. It is worth considering — if you understand three things first.

Most Your Era GLP-1 reviews stop at the price. We read the Terms, both public privacy-policy versions, the Telehealth Consent, and the Refund Policy line by line. There's one sentence in that refund policy that decides whether $79 is a smart bet or an expensive lesson. We'll get to it.

First, the three things.

The verdict, up front

One: the medications are compounded, not FDA-approved. The FDA has not reviewed the finished products for safety, effectiveness, or quality. YourEra says this correctly in its own footer. Anyone who tells you it's "the same as Ozempic" is wrong.

Two: the refund window does not last until delivery. Once the pharmacy begins processing the prescription — before it ships — YourEra's policy says no refund is available.

Three: the headline price has a condition. YourEra's live site rounds the offers to $79 and $159 a month, while current first-party ads describe $79.20 for semaglutide and $159.20 for tirzepatide on six-month plans with a 20% discount. A separate tirzepatide ad lists $207.20 month-to-month. The six-month ads do not show whether you pay up front or in monthly charges. Confirm the amount due today, the billing schedule, and what cancellation stops before you pay.

The FDA-approved Wegovy pill starts at $149 a month through NovoCare Pharmacy. That makes the entry-price gap $69.80, not $1,000 — but it is only a starting-price comparison. It is not a dose-for-dose or product-for-product match.

Best for

A cash-paying adult who wants one of the lowest public starting prices in this category, is fine with a weekly injection, understands they're buying a compounded product, and will save the six-month billing and cancellation terms before paying.

Not for you if

You want FDA-approved brand medication. You want insurance or a government health program billed. You won't use a needle. You need a refund window that stays open after pharmacy processing starts. You want the pharmacy's legal name before checkout.

Quick facts

Prices and terms checked against YourEra's live website, first-party social ads, Terms, and Refund Policy on August 28, 2026.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a matched path before you choose.

What we actually verified

We think you should know exactly how this page was made before you trust a word of it.

Verified directly on August 28, 2026

Provider-stated, not independently tested

• Same price at every dose
• A clinician network covering all 50 states
• Fulfillment through licensed U.S. pharmacies
• Unlimited care messaging and clinician-managed dose changes
• The published 4.8 rating
• The published member outcome numbers
• The six-month 20% discount
• The claim that you are not charged until a provider approves you

Not published anywhere we could verify

• Whether the six-month offer is billed up front or month by month
• What the semaglutide month-to-month price is, if one exists
• What happens to future six-month charges if you cancel early
• The dispensing pharmacy's legal name, state license, and 503A or 503B status
• A state-by-state treatment list
• Support response times or an escalation standard
• The sample size, dates, follow-up period, and method behind the outcome data

What we did not do

We did not sign up. We were not prescribed anything. We have not received or tested a YourEra product. This is a document and price review, not a personal trial. If we ever do a hands-on test, we'll date it and show the screenshots.

Is YourEra legit, or is it a scam?

YourEra appears to be a real operating telehealth business. It publishes legal names, an address, a clinician-review process, payment processors, a named physician founder, and a correct compounded-drug disclosure. That supports "a real business worth evaluating" — not a blanket safety endorsement, and not a promise that the price you saw is the amount you will pay today.

Let's go through what's actually checkable.

The company publishes two legal names and one address

Two names show up in the paperwork, and it's worth knowing both.

The Terms and Conditions say the agreement is with YourEra, Inc. and its subsidiaries or affiliates, under Delaware law. The Privacy Policy identifies Your Era Management, LLC, at 1331 Ochsner Blvd, Suite 200, Covington, LA 70433.

Is that a red flag? No. Plenty of businesses use a parent company and an operating company. But it means the name in the contract may not be the same name that appears on a payment, privacy notice, pharmacy relationship, or support reply. If you ever need to escalate something, save both names.

A real doctor's name is attached to the company

This is the part most pages covering YourEra miss, and it's one of the strongest things they have going for them.

YourEra's clinical articles and video library feature Dr. Tom Lavin. On his own public biography, he says he founded YourEra after working as a bariatric surgeon for more than 25 years. He also says the company owns a compounding pharmacy.

That fills two gaps most reviews miss. Dr. Lavin is not merely a name placed under educational content, and the pharmacy relationship is not described only as an arm's-length vendor relationship. What still remains unpublished is the pharmacy's legal name, license, address, and 503A or 503B status.

That's more than most telehealth GLP-1 brands can show. YourEra is still burying one of its best trust signals — and one of the most important ownership facts a patient would want to verify.

They wrote the hard part correctly

Here's a test we run on every compounded provider: does the fine print tell the truth even when the marketing doesn't have to?

YourEra's footer and FAQ say the compounded products are not the brand-name drugs and are not FDA-approved. That is accurate. The FDA does not review compounded drugs before sale for safety, effectiveness, or quality.

A company trying to fool you does not usually put that sentence in the footer. But a correct footer does not erase stronger claims elsewhere on the same page. You have to read both.

Three document problems worth knowing

One: the acne paragraph. YourEra's Terms include a passage about people ages 13 to 18 using the service only for a medical consultation about topical acne treatment. YourEra's public product catalog does not sell acne care. That reads like a leftover from a broader telehealth template.

Two: the billing conflict. The Consent to Telehealth says the provider will bill insurance or Medicare when applicable. The Terms describe a cash-pay service, say YourEra and related parties are not enrolled in Medicare or Medicaid, and tell users not to submit claims to federal or state health programs. Those documents do not describe the billing model the same way. Ask which one applies before you enter insurance information or assume anything will be billed.

Three: the portal privacy template. YourEra's public Privacy Policy is filled in and dated March 2026. A separate portal privacy-policy page still contains template placeholders for an alternate domain and customer-service email. That is a document-control problem on a page meant to explain how personal data is handled.

None of those facts proves fraud. They do prove the legal copy is not clean or internally consistent across every page.

What "legit" does not prove

Being a real operating business doesn't mean:

• The $79 price is available without a six-month plan
• The six-month plan is billed monthly rather than up front
• The medication is right for you
• The unnamed pharmacy has the license or inspection history you expect
• Every pharmacy used over time will be the same
• The results in YourEra's testimonials will be your results

That's what the rest of this page is for.

How much does YourEra actually cost?

YourEra's live site advertises compounded semaglutide from $79 per month and compounded tirzepatide from $159 per month. Current first-party ads make the missing condition clearer: $79.20 and $159.20 are six-month-plan prices with a 20% discount. A separate tirzepatide ad lists $207.20 month-to-month. Medication, supplies, shipping, dose changes, and care messaging are described as included. The amount charged today and the six-month billing schedule are still not published.

What YourEra publishes right now

Verified on YourEra's live website, current semaglutide ad, and current tirzepatide ad on August 28, 2026.

The part nobody else caught: the "from" price has an answer

The plan condition is not a guess anymore. YourEra now states it in first-party ads. The tirzepatide ad also gives a month-to-month price of $207.20, which is $48 more per month than the six-month-plan figure. We did not find a current semaglutide month-to-month price.

YourEra says:

• The price stays the same at every dose
• The live offer starts at $79 or $159 a month
• Current ads apply a 20% discount to a six-month plan

That explains the word "from." It is tied to plan length, not dose.

What it does not explain is just as important:

• Is the six-month total charged in one payment or six monthly payments?
• If it is six monthly payments, does cancellation stop the remaining charges?
• If it is prepaid, is any unused amount refundable before future prescriptions begin processing?
• Does "no long-term contract" mean you can end the plan early without owing the rest, or only that the plan does not renew after the current term?

YourEra's Terms say cancellation takes effect at the end of the current subscription period. That sentence matters if the discounted subscription period is six months. Save the exact checkout screen before you pay.

Why older Your Era GLP-1 reviews show higher prices

If you've read a few Your Era GLP-1 reviews, you've probably seen numbers that don't match today's site. You're not going crazy. The price moved fast.

Those older reviews were not necessarily lying. They went stale in weeks.

That's the real lesson here, and it's worth more than any single number: in this category, an undated price is worthless. Ours has a date on it. Check it against the live checkout before you pay, because ours will go stale too.

Search metadata still carries older $99 copy

The visible product cards now show $79 and $159. Search-engine snippets attached to some YourEra legal pages have continued to surface older "as low as $99/month" and FSA/HSA copy.

That is not the same as two visible checkout prices. It is still a consistency problem. A person can see one number in search, another number on the homepage, and a more exact number in an ad.

Screenshot the offer you were shown before you pay. If the number or plan changes at checkout, you will have proof of what you were quoted.

HSA and FSA are not guaranteed

YourEra's FAQ says many members use HSA or FSA funds and tells readers to check with their plan administrator. That second sentence is the one to follow.

Treat HSA/FSA eligibility as a question for your plan, not a promise from YourEra. Ask whether your plan requires a Letter of Medical Necessity and whether it reimburses this compounded product and telehealth program.

What's included, and what isn't

YourEra says the program price covers the provider evaluation, a prescription if appropriate, medication, injection supplies, shipping, dose adjustments, and unlimited care messaging.

What it does not currently include:

YourEra Optimum — coaching, a personal nutritionist, an at-home lab draw, and wearable integration — is marked "Coming Soon" on the site. It is not part of what you're buying today. Don't let it factor into your decision until it launches and the included services are written into the current offer.

One pricing oddity worth flagging

YourEra's microdosing protocol starts at $179 a month. Its regular semaglutide program starts at $79.

You pay more than twice as much for a lower-dose protocol.

There may be a real reason — different monitoring, a different formulation, or a different plan. YourEra does not publish one. Its microdosing page also markets the program around mood, focus, momentum, and cognition.

We'll say this plainly: no GLP-1 medication is FDA-approved for mood, focus, or thinking. We did not find completed clinical evidence on YourEra's page that proves those benefits. If your goal is weight loss, judge the weight-loss program on its weight-loss evidence and terms.

### If the six-month price still fits what you were looking for The intake takes about five minutes and checks what is available in your state. Before you submit payment, confirm the amount charged today, whether the plan is prepaid or monthly, what cancellation stops, and the pharmacy's legal name. → See YourEra's current pricing and check your state Prescription required · Compounded medication is not FDA-approved · Treatment is not guaranteed

Is YourEra's medication FDA-approved?

No. YourEra sells compounded semaglutide and compounded tirzepatide. The FDA does not review the finished compounded products for safety, effectiveness, or quality before they are sold. This is different from Wegovy, Ozempic, Zepbound, and Mounjaro, which are FDA-approved products.

Compounded is not the same as generic

This trips up almost everybody, so let's be clear.

A generic drug is FDA-approved. The FDA reviews whether it is the same in the required ways as the brand drug. There is no FDA-approved generic semaglutide or tirzepatide in the United States.

A compounded drug is prepared by a pharmacy for a patient under a prescription. The FDA does not review the finished product before sale.

So if you see "generic Ozempic" or "generic Wegovy" anywhere online, that product does not exist as an FDA-approved generic. Whoever wrote it is either confused or hoping you are.

When compounding is appropriate

Compounding is legal and has a real place in medicine. The FDA says a patient should use a compounded drug only when an approved drug cannot meet that patient's medical needs.

That's a real conversation to have. Here's the question worth asking your prescriber:

"What specific medical need makes a compounded prescription more appropriate for me than an available FDA-approved option?"

If you get a clear answer, good. If you get a vague one, that's information too.

Where YourEra's marketing and fine print disagree

We flagged earlier that YourEra's legal disclaimer is correctly written. Here's the other side of that.

Under "Why Choose YourEra?" the homepage uses the heading "Clinically-Proven Formulas."

The FDA sent warning letters to 30 telehealth companies on March 3, 2026 over false or misleading claims about compounded GLP-1 products. In a separate warning letter, the agency quoted the phrase "clinically proven ingredients" while explaining why the marketing was misleading beside an unapproved compounded product.

Now, to be completely fair to YourEra: we searched the FDA's public warning-letter database and found no letter naming YourEra, YourEra, Inc., or Your Era Management, LLC as of August 28, 2026. We are not saying the company received a letter or broke the law.

We are telling you what the FDA has said about this kind of language, so you can weigh a marketing headline against the disclaimer at the bottom of the same page.

Our read: YourEra's legal disclosure is accurate. The "Clinically-Proven Formulas" headline oversells what can be proved about a compounded finished product. Read the legal disclosure — it tells you what you're actually buying.

What the FDA has flagged about compounded GLP-1s

Not about YourEra specifically. About the category. You should know these before you inject anything:

• As of May 31, 2026, the FDA had received more than 990 adverse-event reports tied to compounded semaglutide and more than 730 tied to compounded tirzepatide — more than 1,720 reports in total
• The FDA says those reports do not prove the drug caused each event, and the totals likely undercount events because many state-licensed pharmacies do not have the same federal reporting duty as outsourcing facilities
• The FDA has warned about dosing errors, especially when patients convert a milligram dose into units on a syringe
• The FDA has warned about semaglutide salt forms, which are different active ingredients from the semaglutide base used in approved products
• The FDA has warned about warm or poorly refrigerated shipments of injectable compounded GLP-1 products
• The FDA says retatrutide and cagrilintide may not be used in compounding under federal law; YourEra does not publicly sell either one

The FDA announced that the semaglutide injection shortage was resolved in February 2025 and the tirzepatide injection shortage in December 2024. After the FDA’s transition periods, shortage status no longer supplied a general basis for routine copies at scale. Patient-specific compounding can still be lawful when the legal requirements are met.

Read the FDA's current page on unapproved GLP-1 drugs used for weight loss, then see our guide to whether compounded GLP-1 medication is still available.

Is YourEra cheaper than FDA-approved Wegovy or Zepbound?

At the public entry price, yes. But the gap is much smaller than old comparisons suggest, and the offers are not dose-for-dose matches. YourEra's semaglutide six-month offer is $79.20 a month. The FDA-approved Wegovy pill starts at $149 a month for the 1.5 mg dose through NovoCare Pharmacy. That entry-price gap is $69.80. YourEra's tirzepatide offer is $159.20 a month, while Zepbound's 2.5 mg self-pay vial starts at $299 — a $139.80 entry gap.

This is the section we'd want to read if we were you, and it's the one most YourEra pages skip entirely.

Brand prices checked against NovoCare's Wegovy savings terms and Lilly's Zepbound savings terms on August 28, 2026. Medication eligibility, dose, offer rules, and refill timing can change the price.

What the entry-price gap is actually buying

Let's be even-handed about this, because it genuinely cuts both ways.

The compounded path can cost less and skips insurance. There is no prior authorization, formulary, or denial letter. For a lot of people, that's the whole point.

The FDA-approved path costs more at these cash prices, and what the extra money buys is real: a product the FDA reviewed for safety, effectiveness, and manufacturing quality; a labeled dose and concentration; a named manufacturer; and an approved prescribing label.

The comparison can also flip if insurance covers the approved medication. The table above is cash pay, not your personal net cost after insurance.

Neither path is right for everybody. But you should make the trade knowingly, not because a headline number made the choice for you.

One time-sensitive note: the $149 Wegovy 4 mg tablet price changes after August 31, 2026. The $199 Wegovy injection intro runs through December 31, 2026. If the FDA-approved path is where you're leaning, those dates matter.

### If that table just changed your mind, that's the right call Seriously. If you want FDA-approved medication, go get FDA-approved medication. It's not a hard decision and we'd rather you make it than talk yourself out of it. → Compare FDA-approved GLP-1 telehealth options Prescription required · Membership, medication, and insurance costs vary by provider

Which pharmacy does YourEra use?

YourEra does not name the dispensing pharmacy on its public consumer pages. Founder Tom Lavin says the company owns a compounding pharmacy, while the Terms also allow prescriptions to move among network pharmacies without notice. Until YourEra gives you the legal pharmacy name, license, address, and compounding status in writing, the pharmacy is still an unresolved part of the purchase.

For a compounded medication, the pharmacy is not a shipping detail. The pharmacy makes the drug. The telehealth platform, medical group, and pharmacy can be different businesses even when they share owners.

503A and 503B, in plain English

Two terms you'll see. Here's what they mean.

A 503A pharmacy generally compounds for an identified patient under a prescription. State pharmacy boards are the main day-to-day regulator, while federal law still applies.

A 503B outsourcing facility registers with the FDA and may compound larger batches under a different federal framework. Registered outsourcing facilities are subject to federal requirements that do not apply in the same way to a typical 503A pharmacy.

Neither label is a magic safety stamp. But the answer tells you where to look, which rules apply, and whether a public FDA registration should exist.

The ownership and transfer facts belong together

YourEra's founder says the company owns a compounding pharmacy. YourEra's Terms also disclose that people tied to the company may have a financial interest in third parties used through the service, and that prescriptions may be transferred among pharmacies without notice.

That does not prove anything improper. It does mean four questions matter:

1. What is the pharmacy's full legal name?
2. Does YourEra, Dr. Lavin, or another related party own all or part of it?
3. Is it operating as a 503A pharmacy, a 503B outsourcing facility, or both through separate operations?
4. Will you be told before your prescription moves to a different pharmacy?

How to check the pharmacy yourself

Ask for the pharmacy information before you pay. Then check it again when the medication arrives.

1. Copy the exact legal name and address from the pharmacy label
2. Search that name on the pharmacy board website for the pharmacy's home state
3. Search your own state board if it requires an out-of-state pharmacy license
4. If the pharmacy claims 503B status, check the FDA's registered outsourcing-facility list
5. Confirm your name and prescriber's name are on the label
6. Check the ingredient, concentration in milligrams per milliliter, and beyond-use date
7. Confirm how many syringe units equal the dose written in milligrams
8. Call the pharmacy directly if the label and your instructions do not match

That ten-minute check is worth more than another hour of reading star ratings.

How does YourEra work, from intake to delivery?

You complete an online medical intake that YourEra says takes about five minutes. A clinician licensed in your state reviews it. If the clinician decides treatment is appropriate, a prescription goes to a pharmacy and the medication is shipped to you. A prescription is not automatic, and the product available to you can depend on your state.

Step 1 — The intake. You enter your health history, current medications, and goals. This is a medical intake, not a quiz. Answer it honestly; the clinician's decision is only as good as what you give them.

Step 2 — Clinician review. A licensed provider reviews the intake and may ask for more information, approve a treatment, recommend something else, or decline treatment.

Step 3 — Payment and pharmacy processing. A current first-party YourEra ad says you are not charged until a provider approves you. The public legal documents do not explain whether YourEra places a temporary card authorization, how fast that hold is released after a decline, or when the pharmacy-processing clock starts.

Step 4 — Shipping and follow-up. If prescribed, a pharmacy prepares and ships the medication. YourEra says shipping, supplies, check-ins, unlimited care messaging, and dose adjustments are included. Those service claims are provider-stated; we did not test response time or care quality.

What “not charged until approved” still leaves unanswered

A provider approval is not the same event as pharmacy processing. That gap matters because the Refund Policy ends refunds when the pharmacy begins processing.

Before you enter payment details, ask:

• Will my card show a temporary authorization before approval?
• What exact charge is made after approval?
• How soon can pharmacy processing begin after that charge?
• If the clinician declines me, how fast is any hold released?
• If the clinician approves a different product or price, do I get a new payment screen before the charge?

YourEra's ad gives a reassuring headline. Those five answers tell you how it works in real life.

Can you cancel YourEra, and can you get a refund?

You can submit a cancellation through the patient portal, but “cancel anytime” has edges. The Terms say you must cancel at least two days before the renewal processing date, cancellation takes effect at the end of the current subscription period, and the first renewal may be charged early. The Refund Policy says no refund is available once the pharmacy begins processing the prescription — even before shipment.

This is the section we opened the page promising. Here is what the documents say in plain English.

Sources: YourEra Terms and Conditions, Refund Policy, Privacy Policy, Consent to Telehealth, and portal Privacy Policy, checked August 28, 2026.

Three notes matter.

On government programs: these Terms do not say that every Medicare or Medicaid beneficiary is banned from paying cash. They say YourEra is not enrolled and that claims must not be submitted to federal or state programs. If you use Medicare, Medicaid, TRICARE, or VA benefits, confirm the rules that apply to you before paying outside the program.

On arbitration: the Terms tell you to mail a signed opt-out to YourEra, Inc. within 30 days but do not print a mailing address in the opt-out instructions. Ask [email protected] for the current address and keep proof of delivery if you choose to opt out.

On HIPAA: YourEra's statement is about the platform itself. It does not mean every clinician or pharmacy handling your care falls outside HIPAA. The medical group and pharmacy can have separate duties and privacy notices.

The honest problem with YourEra

Here's the thing we'd tell a friend.

YourEra does not give you a refund once the pharmacy begins processing your prescription. Not after shipment. Not after delivery. Not because you changed your mind. The cutoff happens before most people feel like the purchase is final.

YourEra says the reason is that pharmacy processing cannot be reversed and the company is invoiced when that work begins. That is the provider's explanation. It does not answer the bigger six-month question: if you chose a six-month offer, does pharmacy processing lock in only the first charge or the whole six-month amount?

Do not guess. Get that answer in writing.

The smart play is not “always choose month-to-month,” because YourEra does not publish a semaglutide month-to-month price and may not offer the same product on that schedule. The smart play is to know the amount charged today, the future charge schedule, and the largest amount that can become nonrefundable before you press pay.

Your true-cost and cancel-by worksheet

Use the numbers from your actual checkout screen. Do not use the homepage number unless checkout matches it.

The two-day date comes from YourEra's Terms. The seven-day date is our planning buffer because the Terms allow an early first renewal. It is not a YourEra promise.

For scale:

• $79.20 × 6 months = $475.20
• $159.20 × 6 months = $955.20

Those totals do not prove that YourEra charges all six months up front. They show why the billing schedule matters. If checkout charges one month at a time, your immediate exposure may be one charge. If checkout charges the full term, the amount at risk may be much larger. Save a screenshot of the final payment page and the cancellation language shown beside it.

### Now you know the questions that decide the risk If the six-month charge schedule, refund cutoff, and pharmacy identity are acceptable to you, the intake checks what is available in your state. → Check YourEra pricing and eligibility Prescription required · Compounded medication is not FDA-approved · Treatment is not guaranteed Not comfortable with that refund window? Use Find My GLP-1 Path and choose a path where refund terms, FDA status, and pharmacy disclosure carry more weight.

What do Your Era GLP-1 reviews actually say?

Here's the honest answer: there is not yet a dependable independent review pool. YourEra publishes a 4.8 out of 5 rating and testimonials, but it does not name the review platform or publish the review count, collection method, or linkable review record. We did not find a stable Trustpilot or BBB profile for yourera.com on August 28, 2026.

We'd rather tell you that than pad this section.

What YourEra publishes about itself

• A 4.8 out of 5 rating, described as based on verified reviews, with no public platform or review count
• Self-reported member outcomes: average body-weight loss of 13.6%, about 29 pounds; 84% reaching at least 5% weight loss; and 100% reporting some weight loss
• Testimonials identified by first name and last initial

YourEra does label the outcome numbers as self-reported. That is better than presenting them as a clinical trial. But the page does not publish the sample size, enrollment dates, follow-up time, definition of a completed member, missing-data rate, or analysis method.

None of that proves the numbers are fake. It means they are provider-owned data that cannot be independently reproduced from what is published. They are not a forecast of what will happen to you.

The “4.9 from 5,000+ verified reviews” claim

A third-party page has claimed that YourEra has a 4.9 rating from more than 5,000 verified reviews.

We looked for the source of that number. We could not match it to YourEra's site, Trustpilot, BBB, or another public review platform. Do not use it in your decision unless the page making the claim can show the review source and collection method.

About the “As featured in” row

YourEra's homepage displays several logos under an “As featured in” heading.

Worth knowing generally, not just here: “as featured in” can mean many things. A quote. A mention. A paid placement. A comparison-page listing. It is not automatically a review or endorsement, and it does not prove that the named outlet evaluated the medication, pharmacy, or care.

The testimonials, used carefully

The testimonials on YourEra's page talk about an easy intake, helpful support, and quick delivery. We are not repeating them as proof of results, safety, or typical shipping time because YourEra selected and published them.

That is the right place to draw the line. A testimonial can tell you what one person says happened. It cannot tell you whether the medication is right for you, whether the pharmacy is consistent, or how often a problem occurs.

What we'd tell you to do about the review gap

A thin review footprint is not proof of a scam. It is proof that the crowd cannot do your homework for you yet.

So judge YourEra on what is checkable: the legal names and address, clinician review, the founder's public identity, the correct FDA disclosure, the six-month price condition, the refund cutoff, the legal-document conflicts, and the unnamed pharmacy.

That evidence is why our verdict is worth considering with specific conditions, not “trust the stars” and not “run away.”

Is YourEra safe?

No article can tell you whether semaglutide or tirzepatide is safe for you. That is a clinician's job, and it depends on your history, other medicines, pregnancy plans, and the exact product the pharmacy makes. What this page can do is show you what to disclose, what to watch for, and what to check before the first injection.

The warnings below come from FDA-approved semaglutide and tirzepatide labels. A compounded product can use a different concentration, container, or set of instructions, so use the pharmacy label and your prescriber's directions for the actual dose.

Tell the clinician about all of these

• A personal or family history of medullary thyroid cancer
• Multiple Endocrine Neoplasia syndrome type 2, or MEN 2
• A prior serious allergic reaction to semaglutide, tirzepatide, or another GLP-1 medicine
• Pancreatitis
• Gallbladder problems
• Kidney problems or past dehydration-related kidney trouble
• Severe stomach or gut problems, including very slow stomach emptying
• Diabetic retinopathy or changing vision
• Insulin or a sulfonylurea, because the combination can raise low-blood-sugar risk
• Pregnancy, breastfeeding, or plans to become pregnant
• Oral birth-control pills if tirzepatide is being considered
• Any upcoming surgery, sedation, or anesthesia
• Every prescription, over-the-counter medicine, supplement, and compounded product you use

Two details are easy to miss:

• The approved Wegovy label says to stop semaglutide at least 2 months before a planned pregnancy because it takes time to clear from the body
• Tirzepatide can make oral hormonal birth control less effective; the approved Zepbound label advises a non-oral method or a barrier method for 4 weeks after starting and for 4 weeks after each dose increase

Tell the surgical or anesthesia team that you use a GLP-1 medicine. These drugs slow stomach emptying, and the approved labels include warnings related to aspiration during procedures using general anesthesia or deep sedation.

Common side effects

Nausea. Diarrhea. Vomiting. Constipation. Stomach pain. Indigestion. Reduced appetite.

These problems can be more noticeable after starting or increasing the dose. “Common” does not mean you should ignore severe symptoms, dehydration, or pain that keeps getting worse.

Call your care team promptly if you have

• Vomiting you cannot stop
• Trouble keeping fluids down
• Signs of dehydration
• Severe or worsening stomach pain
• Repeated low blood sugar
• New or changing vision problems
• Symptoms of a gallbladder problem, such as upper-abdominal pain with fever or yellow skin or eyes
• A dose, concentration, or syringe-unit instruction that does not match the prescription

Get emergency care for trouble breathing, swelling of the face or throat, fainting, severe confusion, or severe and constant abdominal pain — especially when it reaches the back.

Check these ten things before your first injection

This is the checklist we'd tape to the fridge. It takes two minutes and targets the errors the FDA has actually warned about.

1. Your name is on the label
2. The ingredient and form match the prescription
3. The concentration in milligrams per milliliter is printed
4. Your prescribed dose in milligrams is clear
5. You know exactly how many syringe units equal that milligram dose
6. The pharmacy's legal name, address, and phone number are printed
7. A beyond-use date and a prescription or lot identifier are present
8. Storage instructions are included
9. The container and seal are intact
10. The liquid and package look as the pharmacy described — no leaking, unexpected cloudiness, particles, or warmth

If anything does not match, do not inject it. Take a photo, call the dispensing pharmacy, and contact the care team.

If an injectable compounded GLP-1 arrives warm or with poor refrigeration, the FDA says do not use it and contact the pharmacy. A melted ice pack alone does not tell you the medication temperature, so do not guess from the pack. Ask the pharmacy for a product-specific stability answer in writing.

Safety sources: FDA concerns with unapproved GLP-1 drugs, current Wegovy prescribing information, and current Zepbound prescribing information.

YourEra pros and cons

YourEra's real strengths are the low public entry price, bundled program cost, provider-stated flat pricing across doses, named physician founder, and fully online process. Its real limitations are compounded-only GLP-1 medication, a six-month offer with an unpublished billing cadence, no public pharmacy identity, a two-day cancel deadline, legal-document mismatches, and a refund window that closes when pharmacy processing starts.

Who is YourEra right for — and who should pick something else?

YourEra fits a specific person: a cash-paying adult who wants a very low starting price, is fine with a weekly injection, understands the product is compounded, accepts the six-month offer after reading the billing terms, and will get the pharmacy name and cancellation dates in writing. It is the wrong call for someone who needs FDA approval, insurance billing, an oral option, a named pharmacy before payment, or a refund window that lasts beyond pharmacy processing.

We'd rather send you to the right place than the profitable one. Find yourself in this table.

### Does the first row sound like you? Then you know what you're getting into, which puts you ahead of most people who start a GLP-1 online. Save the final checkout screen, pharmacy information, renewal date, and refund rule before you submit payment. → Start the YourEra eligibility check Prescription required · Compounded medication is not FDA-approved · Treatment is not guaranteed

How The RX Index scored YourEra: 72/100

Our provisional score is 72 out of 100, based only on public evidence as of August 28, 2026. The RX Index Score rates providers on five pillars — clinical legitimacy, care quality, transparency, access, and cost. It is an editorial comparison of published evidence. It does not predict weight loss and it does not mean treatment is appropriate for you.

How we score: five pillars, 20 points each, in the same order every time. Points come off for missing or conflicting evidence, not because a company is small or new. Commercial relationships add zero points. Read the full RX Index methodology and editorial standards.

What to verify before you pay

Before you enter payment details, confirm the exact charge, six-month billing schedule, total commitment, renewal date, cancel-by date, refund cutoff, compounded status, pharmacy identity, concentration, syringe units, support route, and insurance or HSA treatment.

Print this. Or screenshot it. It works whether or not you use our link.

• [ ] I know the exact amount charged today
• [ ] I know whether the six-month offer is prepaid or billed in installments
• [ ] I know the total of every scheduled charge in the six-month period
• [ ] I know whether cancellation stops future six-month charges or only the next renewal
• [ ] I know my renewal processing date
• [ ] I know the two-day contractual deadline and my earlier reminder date
• [ ] I know when refund eligibility ends
• [ ] I understand the product is compounded, not FDA-approved
• [ ] I have the dispensing pharmacy's legal name, address, state license, and 503A or 503B status
• [ ] I know the concentration and how many syringe units equal my prescribed milligram dose
• [ ] I know who to contact, how to escalate, and the expected response time
• [ ] I have confirmed any HSA, FSA, insurance, Medicare, Medicaid, TRICARE, or VA rules that apply to me

The ten questions to send YourEra before you pay

Copy this into an email to [email protected]. Their answers — or their silence — will tell you a lot.

1. Your ad says $79.20 or $159.20 on a six-month plan. What exact amount is charged today, and what are all future charge dates?
2. If I cancel during the six-month period, which future charges stop, and when does cancellation take effect?
3. Please confirm that my price stays the same at every dose available under this plan.
4. What is the dispensing pharmacy's full legal name, address, phone number, and state license number?
5. Does YourEra or a related owner have a financial interest in that pharmacy, and is it operating under 503A, 503B, or another lawful structure?
6. If my prescription moves to a different pharmacy, will you notify me before the transfer?
7. Is this exact product and formulation available in my state today?
8. Your ad says I am not charged until approved. Is there a card authorization before approval, and what happens to it if I am declined or offered a different product?
9. What is my renewal processing date, how early can the first renewal charge, and what is my last safe cancellation date?
10. Your Terms say cash pay and no government-program claims, while the Telehealth Consent says a provider may bill insurance or Medicare. Which rule applies to this purchase, and what should I ask my HSA or FSA administrator?

If you send it, come back and tell us what they said. We will publish confirmed answers — including if the company does not answer a material question.

Your Era GLP-1 reviews: frequently asked questions

Is YourEra a scam? We found an identifiable operating telehealth business with published legal names, an address, clinician review, a physician founder, payment processors, and a correct compounded-drug disclosure. We found no evidence that supports calling it a scam. We also did not complete a purchase or independently test the pharmacy, medication, or care. “Real business worth evaluating” is the evidence-based answer.

How much does YourEra cost per month? The live site rounds compounded semaglutide to from $79 a month and compounded tirzepatide to from $159 a month. Current first-party ads describe exact six-month prices of $79.20 and $159.20 with a 20% discount. A separate tirzepatide ad lists $207.20 month-to-month. The public pages do not show whether the six-month plans are prepaid or billed in installments, so confirm the amount due today.

Does the $79 price require six months? Current first-party YourEra ads say the $79.20 semaglutide offer is a six-month plan with a 20% discount. The ad does not show the billing cadence or what early cancellation does to future charges.

Is YourEra FDA-approved? No. YourEra sells compounded semaglutide and compounded tirzepatide. The FDA does not approve the finished compounded products before sale. YourEra states this correctly in its footer and FAQ.

Does YourEra prescribe Ozempic, Wegovy, Mounjaro, or Zepbound? The current YourEra catalog presents compounded semaglutide and compounded tirzepatide, not those brand-name products. If you specifically want an FDA-approved brand, use an approved-medication path.

Can I cancel YourEra any time? You can submit cancellation through the portal, but the Terms say you must act at least two days before the renewal processing date. Cancellation takes effect at the end of the current subscription period, and the first renewal may be charged early. Ask what that means for the remaining charges on a six-month plan.

Can I get a refund from YourEra? Only before the pharmacy begins processing the prescription. Once processing starts, the Refund Policy says no refund is available even if the order has not shipped or arrived. Partly used subscription periods are not refunded.

Does YourEra take insurance? The Terms describe YourEra as cash pay and say the company is not enrolled in Medicare or Medicaid. They also say claims must not be submitted to federal or state health programs. A separate Telehealth Consent says a provider may bill insurance or Medicare when applicable. Because those documents conflict, confirm in writing what applies to your checkout.

Can someone with Medicare or Medicaid use YourEra? The Terms do not say every beneficiary is forbidden from paying cash. They say YourEra is not enrolled and that program claims must not be submitted. Paying outside a government program can have rules and consequences, so confirm them before purchase.

Can I use my HSA or FSA? YourEra says many members use HSA or FSA funds and tells users to check with the plan administrator. Eligibility can depend on the exact expense and documentation. Do not treat the website statement as approval from your plan.

What pharmacy does YourEra use? YourEra does not publish the pharmacy's legal name on its consumer pages. Founder Tom Lavin says the company owns a compounding pharmacy, and the Terms allow prescriptions to transfer among pharmacies without notice. Ask for the pharmacy name, license, address, ownership, and 503A or 503B status before payment.

Is YourEra available in my state? YourEra says its clinician network covers all 50 states, but specific treatment availability varies by state. It does not publish a complete state-by-product list. The intake or a written support answer is the current way to confirm.

Does the price rise when my dose increases? YourEra says the price stays the same at every dose. We are reporting that as a provider-stated policy. Save the checkout terms and ask whether it applies to every dose and formulation under your exact plan.

Does YourEra offer GLP-1 pills? The GLP-1 products shown in the current catalog are weekly injections. The separate NAD+ program offers other forms, but that is not a GLP-1 weight-loss treatment.

Are labs, coaching, and nutrition included? Not in the current base offer. YourEra Optimum lists coaching, nutrition, an at-home lab draw, and wearable integration as coming soon. Do not count those future services in today's price.

What is YourEra's microdosing program? It is a lower-dose protocol advertised from $179 a month — more than twice the regular semaglutide starting price. YourEra markets it around mood, focus, momentum, and cognition. No GLP-1 drug is FDA-approved for those uses, and the page does not publish completed clinical evidence proving those benefits.

Does YourEra have independent customer reviews? YourEra publishes a 4.8 rating and provider-owned testimonials but does not name the review platform or publish the count and collection method. As of August 28, 2026, we did not find a stable Trustpilot or BBB profile for yourera.com. Isolated anonymous comments are not enough to create a dependable review record.

Who is behind YourEra? YourEra's documents use YourEra, Inc. and Your Era Management, LLC. Dr. Tom Lavin says on his public biography that he founded the company after more than 25 years in bariatric surgery and that YourEra owns a compounding pharmacy. The public consumer pages do not name that pharmacy.

The bottom line on YourEra

YourEra appears to be a real operating company selling compounded GLP-1 treatment at genuinely low public entry prices. It gives the correct FDA disclosure, requires clinician review, publishes its main legal documents, and has a named physician founder.

The damaging admissions matter just as much: the headline price is a six-month offer; the billing cadence and amount due today are not public; the pharmacy is unnamed even though the founder says the company owns one; the refund window closes when pharmacy processing begins; and the legal documents do not tell one clean story about insurance billing.

The trade is specific. You are giving up FDA approval, a public pharmacy identity, and a longer refund window in exchange for a low cash price and a simple online path.

The FDA-approved Wegovy pill starts at $149, so the entry-price gap against YourEra semaglutide is $69.80 a month at the current starting offers. That is a real gap. It is also a dose-specific, time-sensitive comparison — not proof that every approved option costs only $69.80 more.

If you want YourEra, do four things before you pay: save the final quote, confirm the full six-month charge schedule, get the pharmacy name in writing, and set a reminder at least a week before the renewal processing date. Those steps do not remove the risk. They make the risk visible.

If any part of this made you hesitate, that hesitation is information. There is an FDA-approved path, an insurance path, and an oral-treatment path. You do not need to talk yourself into the wrong one because the first number was low.

### Ready to see what YourEra would charge you? The intake checks state availability and requires clinician approval. Read the final payment screen before submitting it, because that is where the six-month billing and amount due today must be confirmed. → Check YourEra's current pricing and eligibility Prescription required · Compounded medication is not FDA-approved · Treatment is not guaranteed

Still not sure which GLP-1 path fits you? Use the free Find My GLP-1 Path tool.

The right provider depends on your state, insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred format, and your budget. A general verdict cannot resolve those for you; the routing tool is built to do that part.

How we made this page

Who wrote it: The RX Index Editorial Team.

How we produced it: On August 28, 2026, we read YourEra's live website, current semaglutide ad, current tirzepatide ad, Terms and Conditions, Refund Policy, public Privacy Policy, separate portal Privacy Policy, Consent to Telehealth, and founder biography. We searched the FDA warning-letter database for YourEra-related names, checked the FDA's current compounded-GLP-1 safety page and shortage history, pulled current cash prices from NovoCare and Lilly, and searched major independent review surfaces.

What we did not do: We did not enroll, were not prescribed anything, and have not received or tested a YourEra product. This is a document, offer, and price review — not a personal trial or laboratory test.

Why this page exists: Because the things that actually cost people money are in the screens and documents most people skip.

Nothing on this page is medical advice. GLP-1 medications have real contraindications, interactions, and side effects. Talk to a licensed clinician who knows your history before starting, stopping, or changing treatment. For an emergency, contact emergency services rather than a website support team.

Primary sources checked

• YourEra live website
• YourEra semaglutide six-month ad
• YourEra tirzepatide six-month and month-to-month ad
• YourEra Terms and Conditions
• YourEra Refund Policy
• YourEra Privacy Policy
• YourEra Consent to Telehealth
• YourEra portal Privacy Policy
• Dr. Tom Lavin's public biography
• FDA concerns with unapproved GLP-1 drugs used for weight loss
• FDA action against misleading compounded-GLP-1 telehealth claims
• FDA warning letter quoting “clinically proven ingredients”
• FDA registered outsourcing facilities
• NovoCare Wegovy savings terms
• Lilly Zepbound savings terms
• Wegovy prescribing information
• Zepbound prescribing information

Read our editorial standards, scoring methodology, and corrections policy.

Update log